&#xa0;&#xa0;Executive Summary

[[[&#xa0;]]]•&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; The NFU recognises the importance of antimicrobial resistance as a fundamental threat to animals and humans alike.&#xa0;•&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; The NFU believes that antimicrobials are a precious resource and their effectiveness must be protected.&#xa0;•&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; Scientific evidence increasingly recognises that the problem of antimicrobial resistance in humans is a consequence of irresponsible use of antimicrobials in human medicine.&#xa0;•&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; Minimising the risk of disease on farm through the development and implementation of farm health planning and disease reduction strategies are an important aspect of reducing the need for antimicrobials on farm. &#xa0;•&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; Even with the best of care however, farm animals will still get sick and may need antimicrobial treatment. These antimicrobials are available only with a veterinary prescription and it is the veterinary surgeon who decides what to administer and when to use them. The livestock keeper must ensure that these instructions are adhered to, as well as meeting regulatory commitments such as recording the use and treatment regime.&#xa0;•&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; The NFU fundamentally supports the principle of responsible use of antimicrobials which means using them as little as possible and as much as necessary.&#xa0;•&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; The NFU feels that the UK’s intervention strategy for reducing the impact and development of antimicrobial resistance hinges around identifying and avoiding high risk practices, and believes that this is where the responsible use principles, as developed and promoted by RUMA, should be fully supported.&#xa0;•&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; The NFU is opposed to setting targets or level of use restrictions, as implemented in some other EU Member States. Reducing dosages or the length of treatment simply to use a lesser quantity of antimicrobials to meet reduction targets is not responsible use. It could in fact encourage the development of antimicrobial resistance, compromise animal health and welfare and encourage illegal practices.&#xa0;Introduction

[[[&#xa0;]]]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;How has antimicrobial resistance developed in the past decade?&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;What are the gaps in our knowledge about antimicrobial resistance?&#xa0;&#xa0;&#xa0;Is there sufficient research and investment into new antibiotics or other treatments and methods to ensure continued protection against infection? If not, how could this be rectified?&#xa0;&#xa0;&#xa0;&#xa0;What measures (including behavioural change) have been most effective in controlling the spread of resistant pathogens, and could such measures be used to control other pathogens?&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;What global coordination and action is required to fight antimicrobial resistance and is the UK contributing enough towards cross-border initiatives?&#xa0;&#xa0;&#xa0;&#xa0;What are the strengths and weaknesses of the Government’s 2013-2018 strategy for tackling antimicrobial resistance? What changes might be made to further strengthen the Government’s action plan?&#xa0;&#xa0;&#xa0;&#xa0;November 2013&#xa0;